No abstract available
MeSH terms
-
Biosimilar Pharmaceuticals* / adverse effects
-
Biosimilar Pharmaceuticals* / pharmacokinetics
-
Biosimilar Pharmaceuticals* / therapeutic use
-
Biotechnology
-
Drug Approval / legislation & jurisprudence
-
European Union
-
Humans
-
Risk Management
-
Therapeutic Equivalency
Substances
-
Biosimilar Pharmaceuticals